Active Ingredient History
Prednisone is a glucocorticoid medication mostly used to suppress the immune system and decrease inflammation in conditions such as asthma, COPD, and rheumatologic diseases. It is also used to treat high blood calcium due to cancer and adrenal insufficiency along with other steroids. It is taken by mouth. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Combination drugs
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Addison Disease (approved 1955)
Anemia, Diamond-Blackfan (approved 2012)
Crohn Disease (approved 2012)
Dermatitis, Allergic Contact (approved 1972)
Eczema (approved 1972)
Hematologic Diseases (approved 1955)
Hypersensitivity (approved 1955)
Iritis (approved 1973)
Keratitis (approved 1973)
Keratitis, Herpetic (approved 1973)
Leukemia, Biphenotypic, Acute (approved 1955)
Lymphoma (approved 2012)
Mycosis Fungoides (approved 1955)
Psoriasis (approved 1972)
Rheumatic Diseases (approved 1955)
Rosacea (approved 1973)
Stevens-Johnson Syndrome (approved 2012)
Uveitis (approved 1955)
Abdominal Wall (Phase 1)
Abortion, Habitual (Phase 4)
Acne Vulgaris (Phase 4)
Adenocarcinoma (Phase 1)
Adipose Tissue, Brown (Phase 4)
Adrenal Cortex Hormones (Phase 4)
Adrenal Hyperplasia, Congenital (Phase 4)
Adrenal Insufficiency (Phase 4)
Adrenocortical Carcinoma (Phase 1)
Affective Disorders, Psychotic (Phase 4)
AIDS-Associated Nephropathy (Phase 2)
Airway Management (Phase 4)
Allergy and Immunology (Phase 2)
Allografts (Phase 3)
Alzheimer Disease (Phase 3)
Amyotrophic Lateral Sclerosis (Phase 2)
Analgesics, Opioid (Phase 4)
Anemia (Phase 3)
Anemia, Aplastic (Phase 2)
Anemia, Diamond-Blackfan (Phase 1/Phase 2)
Anemia, Hemolytic (Phase 2)
Anemia, Hemolytic, Autoimmune (Phase 3)
Anemia, Sickle Cell (Phase 3)
Anesthesia (Phase 4)
Aneurysm (Phase 3)
Angioedema (Phase 3)
Anti-Inflammatory Agents (Phase 2/Phase 3)
Arterial Occlusive Diseases (Phase 3)
Arthritis, Juvenile (Phase 4)
Ascites (Phase 3)
Aspergillosis, Allergic Bronchopulmonary (Phase 2/Phase 3)
Asthma ()
Atherosclerosis (Phase 3)
Autoimmune Diseases (Phase 4)
Barrett Esophagus (Phase 4)
Bartonella Infections (Phase 4)
Behcet Syndrome (Phase 2)
Bell Palsy (Phase 4)
beta-Thalassemia (Phase 2)
Biliary Atresia (Phase 3)
Birdshot Chorioretinopathy (Phase 2)
Bone Marrow Failure Disorders (Phase 2)
Bone Marrow Transplantation (Phase 2)
Brain Injuries (Phase 2)
Brain Neoplasms (Phase 3)
Breast Neoplasms (Phase 3)
Bronchiolitis Obliterans (Phase 2)
Burkitt Lymphoma (Phase 4)
Carcinoma (Phase 3)
Carcinoma, Basal Cell (Phase 1)
Carcinoma, Giant Cell (Phase 2)
Carcinoma, Hepatocellular (Phase 3)
Carcinoma, Merkel Cell (Phase 1)
Carcinoma, Non-Small-Cell Lung (Phase 1)
Carcinoma, Ovarian Epithelial (Phase 1)
Carcinoma, Renal Cell (Phase 2)
Carcinoma, Squamous Cell (Phase 1)
Cardiomyopathies (Phase 4)
Cardiotoxicity (Phase 3)
Cardiovascular Diseases (Phase 4)
Castleman Disease (Phase 2)
Castration (Phase 3)
Cataract (Phase 4)
Cat-Scratch Disease (Phase 4)
Celiac Disease (Phase 2/Phase 3)
Cellulitis (Phase 2)
Cerebellar Diseases (Phase 2)
Chondrocalcinosis (Phase 4)
Chorioretinitis (Phase 3)
Choroidal Effusions (Phase 4)
Chronic Disease (Phase 4)
Chronic Pain (Phase 3)
Churg-Strauss Syndrome (Phase 4)
Cocaine-Related Disorders (Phase 2)
Cognition Disorders (Phase 2)
Cognitive Dysfunction (Phase 3)
Colitis (Phase 2)
Colorectal Neoplasms (Phase 1)
Community-Acquired Infections (Phase 3)
Comparative Study (Phase 4)
Conjunctivitis (Phase 4)
Connective Tissue Diseases (Phase 4)
Corneal Diseases (Phase 2)
Corneal Edema (Phase 4)
Corneal Transplantation (Phase 4)
Corneal Ulcer (Phase 4)
Coronary Artery Disease (Phase 2/Phase 3)
Cough (Phase 4)
COVID-19 (Phase 4)
Cranial Nerve Diseases (Phase 1/Phase 2)
Craniopharyngioma (Phase 4)
Croup (Phase 4)
Cryoglobulinemia (Phase 2)
Cryptogenic Organizing Pneumonia (Phase 2)
Cushing Syndrome (Phase 2)
Cystic Fibrosis (Phase 3)
Cytokines (Phase 2)
Cytomegalovirus (Phase 4)
Cytomegalovirus Infections (Phase 4)
Dapsone (Phase 3)
Deficiency Diseases (Phase 2)
Dermatitis, Allergic Contact (Phase 1/Phase 2)
Dermatitis, Contact (Phase 3)
Dermatitis, Seborrheic (Phase 3)
Desmoplastic Small Round Cell Tumor (Phase 1)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 1 (Phase 1/Phase 2)
Diabetes Mellitus, Type 2 (Phase 4)
Diabetic Retinopathy (Phase 3)
Diagnosis (Phase 3)
Diarrhea (Phase 2)
DiGeorge Syndrome (Phase 2)
DNA Repair-Deficiency Disorders (Phase 2)
Down Syndrome (Phase 3)
Drug Evaluation (Phase 4)
Drug Hypersensitivity Syndrome (Early Phase 1)
Drug Interactions (Phase 4)
Drugs, Investigational (Phase 4)
Drug Therapy, Combination (Phase 2)
Dry Eye Syndromes (Phase 4)
Dyslipidemias (Early Phase 1)
Eczema (Phase 4)
Embolism, Cholesterol (Phase 2)
Encephalitis (Phase 2)
Endocardial Cushion Defects (Phase 3)
Endoscopy (Phase 2)
Enteropathy-Associated T-Cell Lymphoma (Phase 4)
Eosinophilia (Phase 4)
Eosinophils (Phase 4)
Epilepsy (Phase 4)
Epiretinal Membrane (Phase 4)
Erysipelas (Phase 2)
Esophageal Achalasia (Phase 4)
Esophageal Diseases (Phase 1)
Esophageal Stenosis (Phase 4)
Eye Infections (Phase 3)
Eye Infections, Bacterial (Phase 4)
Facial Nerve Injuries (Phase 3)
Fanconi Anemia (Phase 1)
Fatigue (Phase 4)
Fecal Microbiota Transplantation (Phase 2/Phase 3)
Fuchs' Endothelial Dystrophy (Phase 4)
Gastrointestinal Neoplasms (Phase 1)
General Surgery (Phase 4)
Geriatrics (Phase 3)
Gestational Trophoblastic Disease (Phase 2)
Giant Cell Arteritis (Phase 4)
Glaucoma (Phase 4)
Glomerulonephritis (Phase 3)
Glomerulonephritis, IGA (Phase 4)
Glomerulonephritis, Membranous (Phase 3)
Glomerulosclerosis, Focal Segmental (Phase 3)
Glucocorticoids (Phase 4)
Glucose Intolerance (Phase 1)
Glycogen Storage Disease Type I (Phase 3)
Gout (Phase 2)
Graft Rejection (Phase 4)
Graft vs Host Disease (Phase 4)
Granuloma (Phase 4)
Granulomatosis with Polyangiitis (Phase 4)
Graves Ophthalmopathy (Phase 4)
Headache (Phase 3)
Healthcare-Associated Pneumonia (Phase 4)
Healthy Volunteers (Phase 4)
Hearing Loss (Phase 3)
Hearing Loss, Sensorineural (Phase 3)
Hearing Loss, Sudden (Phase 3)
Heart Diseases (Phase 4)
Heart Failure (Phase 4)
Heart Transplantation (Phase 3)
Hemangioma (Phase 4)
Hematologic Diseases (Phase 4)
Hematoma (Phase 3)
Hematopoietic Stem Cell Transplantation (Phase 2)
Hemoglobinopathies (Phase 2)
Hemoglobin SC Disease (Phase 2)
Hemoglobinuria (Phase 2)
Hemoglobinuria, Paroxysmal (Phase 2)
Hemolysis (Phase 2)
Hemophilia A (Phase 4)
Hepatitis, Alcoholic (Phase 4)
Hepatitis, Autoimmune (Phase 4)
Hepatitis B (Phase 2)
Hepatitis B, Chronic (Phase 4)
Hepatitis C (Phase 3)
Hepatitis C, Chronic (Phase 2)
Hepatolenticular Degeneration (Phase 1/Phase 2)
Hermanski-Pudlak Syndrome (Phase 2)
Herpesvirus 8, Human (Phase 2)
Histiocytosis, Langerhans-Cell (Phase 3)
HIV (Phase 3)
HIV Infections (Phase 4)
Hodgkin Disease (Phase 4)
Hormones (Phase 2)
HTLV-I Infections (Phase 1)
Hypereosinophilic Syndrome (Phase 4)
Hyperglycemia (Phase 1)
Hyperpigmentation (Phase 4)
Hypersensitivity (Phase 3)
Hyperuricemia (Phase 4)
Idiopathic Pulmonary Fibrosis (Phase 3)
IgA Vasculitis (Phase 4)
Immune System Diseases (Phase 2)
Immunoglobulin G4-Related Disease (Phase 4)
Immunoglobulins (Phase 3)
Immunosuppression Therapy (Phase 4)
Immunosuppressive Agents (Phase 4)
Infections (Phase 3)
Infertility (Phase 4)
Inflammation ()
Inflammatory Bowel Diseases (Phase 2/Phase 3)
Inosine Triphosphate (Phase 2/Phase 3)
Intellectual Disability (Phase 4)
Intestinal Diseases (Phase 4)
Intestinal Neoplasms (Phase 2)
Intraocular Lymphoma (Phase 1/Phase 2)
Iritis (Phase 2)
Kasabach-Merritt Syndrome (Phase 2)
Keratitis (Phase 3)
Keratitis, Herpetic (Phase 3)
Kidney Diseases (Phase 4)
Kidney Failure, Chronic (Phase 4)
Kidney Glomerulus (Phase 4)
Kidney Neoplasms (Phase 2)
Kidney Transplantation (Phase 4)
Lambert-Eaton Myasthenic Syndrome (Phase 2)
Leber Congenital Amaurosis (Phase 2)
Lenalidomide (Phase 2)
Leprosy (Phase 2/Phase 3)
Leukemia ()
Leukemia, B-Cell (Phase 2)
Leukemia, Hairy Cell (Phase 2)
Leukemia, Large Granular Lymphocytic (Phase 2/Phase 3)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 4)
Leukemia, Lymphoid (Phase 4)
Leukemia-Lymphoma, Adult T-Cell (Phase 4)
Leukemia, Myeloid, Acute (Phase 3)
Leukemia, Myeloid, Chronic-Phase (Phase 2)
Leukemia, Myelomonocytic, Chronic (Phase 2)
Leukocyte Disorders (Phase 4)
Lichen Planus, Oral (Phase 4)
Lipoma (Phase 1/Phase 2)
Livedoid Vasculopathy (Phase 4)
Liver Cirrhosis (Phase 3)
Liver Cirrhosis, Biliary (Phase 4)
Liver Diseases, Alcoholic (Phase 3)
Liver Failure (Phase 2)
Liver Failure, Acute (Phase 4)
Liver Transplantation (Phase 4)
Living Donors (Phase 3)
Long QT Syndrome (Phase 4)
Lung Diseases (Phase 4)
Lung Diseases, Interstitial (Phase 4)
Lung Diseases, Obstructive (Phase 4)
Lung Neoplasms (Phase 4)
Lung Transplantation (Phase 2)
Lupus Nephritis (Phase 3)
Lymphadenopathy (Phase 1/Phase 2)
Lymphatic Diseases (Phase 2)
Lymphocytes (Phase 2)
Lymphoma ()
Lymphoma, AIDS-Related (Phase 2)
Lymphoma, B-Cell (Phase 4)
Lymphoma, B-Cell, Marginal Zone (Phase 3)
Lymphoma, Extranodal NK-T-Cell (Phase 3)
Lymphoma, Follicular (Phase 4)
Lymphoma, Large B-Cell, Diffuse (Phase 4)
Lymphoma, Large-Cell, Anaplastic (Phase 4)
Lymphoma, Large-Cell, Immunoblastic (Phase 3)
Lymphoma, Mantle-Cell (Phase 4)
Lymphoma, Non-Hodgkin (Phase 4)
Lymphoma, Primary Effusion (Phase 1/Phase 2)
Lymphoma, T-Cell (Phase 4)
Lymphoma, T-Cell, Peripheral (Phase 4)
Lymphomatoid Granulomatosis (Phase 2)
Lymphoproliferative Disorders (Phase 2)
Macula Lutea (Phase 4)
Macular Edema (Phase 4)
Malaria (Phase 3)
Mediastinal Neoplasms (Phase 4)
Medulloblastoma (Phase 4)
Meibomian Gland Dysfunction (Phase 4)
Melanoma (Phase 2)
Microscopic Polyangiitis (Phase 4)
Morals (Phase 4)
Mucocutaneous Lymph Node Syndrome (Phase 3)
Multiple Myeloma (Phase 4)
Multiple Sclerosis, Relapsing-Remitting (Phase 4)
Muscular Dystrophies, Limb-Girdle (Phase 2)
Muscular Dystrophy, Duchenne (Phase 3)
Mutation (Phase 2)
Myasthenia Gravis (Phase 4)
Mycophenolic Acid (Phase 4)
Myelodysplastic Syndromes (Phase 2)
Myeloproliferative Disorders (Phase 2)
Myocardial Ischemia (Phase 2/Phase 3)
Myocarditis (Phase 4)
Myocardium (Phase 4)
Nasal Polyps (Phase 4)
Nasopharyngeal Carcinoma (Phase 2)
Natural Killer T-Cells (Phase 3)
Neoplasm Metastasis (Phase 3)
Neoplasms (Phase 3)
Neoplasms, Germ Cell and Embryonal (Phase 4)
Nephritis (Phase 4)
Nephrosis, Lipoid (Phase 4)
Neuroblastoma (Phase 3)
Neuromyelitis Optica (Phase 4)
Neutropenia (Phase 2)
N-Myc Proto-Oncogene Protein (Phase 2)
Ocular Hypertension (Phase 4)
Opioid-Related Disorders (Phase 2)
Opsoclonus-Myoclonus Syndrome (Phase 2)
Optic Disk (Phase 4)
Optic Neuritis (Phase 3)
Optic Neuropathy, Ischemic (Phase 2)
Oral Ulcer (Phase 2)
Organ Transplantation (Phase 4)
Oropharyngeal Neoplasms (Phase 2)
Osteoarthritis, Knee (Phase 4)
Osteoradionecrosis (Phase 2)
Ovarian Neoplasms (Phase 2)
Pain (Phase 4)
Pain, Postoperative (Phase 3)
Panuveitis (Phase 4)
Papilledema (Phase 4)
Paranasal Sinus Diseases (Phase 3)
Pathologic Processes (Phase 2)
Pemphigoid, Bullous (Phase 4)
Pemphigus ()
Pericarditis, Tuberculous (Phase 3)
Peritoneal Neoplasms (Phase 1)
Pharmacokinetics (Phase 1)
Pharmacology (Phase 1)
Pituitary Neoplasms (Phase 4)
Plasmablastic Lymphoma (Phase 2)
Plasmacytoma (Phase 2)
Pneumonia ()
Pneumonia, Pneumocystis (Phase 4)
Polyarteritis Nodosa (Phase 4)
Polycystic Ovary Syndrome (Phase 4)
Polycythemia Vera (Phase 2)
Polymorphism, Genetic (Phase 2)
Polymyalgia Rheumatica (Phase 4)
Polymyositis ()
Polyradiculoneuropathy (Phase 3)
Postmenopause (Phase 2)
Postoperative Complications (Phase 3)
Postoperative Nausea and Vomiting (Phase 2)
Precancerous Conditions (Phase 1)
Pregnancy Complications (Phase 3)
Primary Myelofibrosis (Phase 2)
Prognosis (Phase 2)
Prostatectomy (Phase 2)
Prostatic Neoplasms (Phase 4)
Proteinuria (Phase 2)
Pruritus (Phase 2)
Pseudophakia (Phase 4)
Psoriasis (Phase 4)
Psychotic Disorders (Phase 4)
Pulmonary Disease, Chronic Obstructive (Phase 4)
Pulmonary Eosinophilia (Phase 4)
Pulmonary Fibrosis (Phase 2)
Pulpitis (Phase 4)
Purpura (Phase 4)
Purpura, Thrombotic Thrombocytopenic (Phase 3)
Quality of Life (Phase 3)
Radiation Pneumonitis (Phase 2)
Regional Blood Flow (Phase 4)
Renal Dialysis (Phase 4)
Renal Insufficiency (Phase 4)
Renal Insufficiency, Chronic (Phase 4)
Renal Replacement Therapy (Phase 4)
Respiration, Artificial (Phase 4)
Respiratory Sounds (Phase 4)
Respiratory Syncytial Virus Infections (Phase 1)
Respiratory Tract Infections (Phase 4)
Retinal Diseases (Phase 4)
Retinal Vein Occlusion (Phase 2/Phase 3)
Retroperitoneal Fibrosis (Phase 4)
Retroperitoneal Neoplasms (Phase 1)
Rhabdomyosarcoma (Phase 1)
Rhinitis (Phase 3)
Rhinitis, Allergic (Phase 3)
Rhinitis, Allergic, Perennial (Phase 3)
Safety (Phase 1)
Sarcoidosis ()
Sarcoidosis, Pulmonary (Phase 3)
Sarcoma (Phase 2)
Sarcoma, Kaposi (Phase 2)
Schizophrenia (Phase 4)
Sciatica (Phase 3)
Sciatic Neuropathy (Phase 3)
Sclerosis (Phase 2)
Sepsis (Phase 4)
Signs and Symptoms, Respiratory (Phase 4)
Sinusitis (Phase 4)
Sjogren's Syndrome (Phase 4)
Sleep Apnea, Obstructive (Phase 4)
Small Cell Lung Carcinoma (Phase 2)
Spasms, Infantile (Phase 3)
Spinal Injuries (Phase 4)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Status Asthmaticus (Phase 4)
Steroids (Phase 3)
Stiff-Person Syndrome (Phase 2)
Stomatitis (Phase 2)
Systemic Vasculitis (Phase 2)
Takayasu Arteritis (Phase 2/Phase 3)
Testicular Neoplasms (Phase 3)
Thalassemia (Phase 2)
Thalidomide (Phase 3)
Thrombocythemia, Essential (Phase 2)
Thrombocytopenia (Phase 4)
Thrombocytosis (Phase 2)
Thrombosis (Phase 2)
Thymoma (Phase 2)
Thyroid Diseases (Phase 4)
Thyroid Gland (Phase 3)
Thyroiditis, Subacute (Phase 4)
Tracheal Stenosis (Phase 4)
Translocation, Genetic (Phase 2)
Triple Negative Breast Neoplasms (Phase 1)
Tuberculosis (Phase 3)
Urination Disorders (Phase 2)
Urologic Neoplasms (Phase 1)
Urticaria (Phase 3)
Uveitis (Phase 4)
Uveitis, Anterior (Phase 3)
Uveitis, Intermediate (Phase 4)
Uveitis, Posterior (Phase 4)
Vasculitis (Phase 4)
Vasculitis, Central Nervous System (Phase 2)
Vasculitis, Leukocytoclastic, Cutaneous (Phase 2)
Vasovasostomy (Phase 4)
Vestibular Diseases (Phase 4)
Vestibular Neuronitis (Phase 4)
Vision Disorders (Phase 2)
Visual Pathways (Phase 4)
Vitrectomy (Phase 4)
Vitreoretinopathy, Proliferative (Phase 4)
Waldenstrom Macroglobulinemia (Phase 2)
Wilms Tumor (Phase 1)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
